$CPIX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CUMBERLAND PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CUMBERLAND PHARMACEUTICALS INC. Get notifications about new insider transactions in CUMBERLAND PHARMACEUTICALS INC for free.
Page: < prev 1 ... 2 3 4 5 6 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Grant | A | 6.70 | 5,000 | 33,500 | 145,557 | 140.6 K to 145.6 K (+3.56 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Pavliv Leo | SVP and Chief Devel ... | Payment of Exercise | F | 6.70 | 2,557 | 17,132 | 130,304 | 132.9 K to 130.3 K (-1.92 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Pavliv Leo | SVP and Chief Devel ... | Payment of Exercise | F | 6.70 | 2,557 | 17,132 | 130,304 | 132.9 K to 130.3 K (-1.92 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Pavliv Leo | SVP and Chief Devel ... | Grant | A | 6.70 | 25,000 | 167,500 | 132,861 | 107.9 K to 132.9 K (+23.18 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Pavliv Leo | SVP and Chief Devel ... | Grant | A | 6.70 | 25,000 | 167,500 | 132,861 | 107.9 K to 132.9 K (+23.18 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Herman James L | VP and Chief Compli ... | Payment of Exercise | F | 6.70 | 2,999 | 20,093 | 42,949 | 45.9 K to 42.9 K (-6.53 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Herman James L | VP and Chief Compli ... | Payment of Exercise | F | 6.70 | 2,999 | 20,093 | 42,949 | 45.9 K to 42.9 K (-6.53 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Herman James L | VP and Chief Compli ... | Grant | A | 6.70 | 3,000 | 20,100 | 45,948 | 42.9 K to 45.9 K (+6.99 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Herman James L | VP and Chief Compli ... | Grant | A | 6.70 | 3,000 | 20,100 | 45,948 | 42.9 K to 45.9 K (+6.99 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | KAZIMI A J | Chairman and CEO | Payment of Exercise | F | 6.70 | 24,373 | 163,299 | 5,905,897 | 5.9 M to 5.9 M (-0.41 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | KAZIMI A J | Chairman and CEO | Payment of Exercise | F | 6.70 | 24,373 | 163,299 | 5,905,897 | 5.9 M to 5.9 M (-0.41 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | KAZIMI A J | Chairman and CEO | Grant | A | 6.70 | 100,000 | 670,000 | 5,930,270 | 5.8 M to 5.9 M (+1.72 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | KAZIMI A J | Chairman and CEO | Grant | A | 6.70 | 100,000 | 670,000 | 5,930,270 | 5.8 M to 5.9 M (+1.72 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Bernard Gordon R | Director | Grant | A | 6.70 | 1,000 | 6,700 | 118,729 | 117.7 K to 118.7 K (+0.85 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Bernard Gordon R | Director | Grant | A | 6.70 | 1,000 | 6,700 | 118,729 | 117.7 K to 118.7 K (+0.85 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Griggs Jonathan | Director | Grant | A | 6.70 | 1,000 | 6,700 | 11,803 | 10.8 K to 11.8 K (+9.26 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Griggs Jonathan | Director | Grant | A | 6.70 | 1,000 | 6,700 | 11,803 | 10.8 K to 11.8 K (+9.26 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Jones James | Director | Grant | A | 6.70 | 1,000 | 6,700 | 11,700 | 10.7 K to 11.7 K (+9.35 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Jones James | Director | Grant | A | 6.70 | 1,000 | 6,700 | 11,700 | 10.7 K to 11.7 K (+9.35 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Young Caroline | Director | Grant | A | 6.70 | 1,000 | 6,700 | 3,000 | 2 K to 3 K (+50.00 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Young Caroline | Director | Grant | A | 6.70 | 1,000 | 6,700 | 3,000 | 2 K to 3 K (+50.00 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | JACOBS JOEY A | Director | Grant | A | 6.70 | 5,000 | 33,500 | 66,000 | 61 K to 66 K (+8.20 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | JACOBS JOEY A | Director | Grant | A | 6.70 | 5,000 | 33,500 | 66,000 | 61 K to 66 K (+8.20 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Bonner Michael | Chief Financial Off ... | Payment of Exercise | F | 6.70 | 843 | 5,648 | 17,654 | 18.5 K to 17.7 K (-4.56 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Bonner Michael | Chief Financial Off ... | Grant | A | 6.70 | 2,500 | 16,750 | 18,497 | 16 K to 18.5 K (+15.63 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Bonner Michael | Chief Financial Off ... | Payment of Exercise | F | 6.70 | 843 | 5,648 | 17,654 | 18.5 K to 17.7 K (-4.56 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Bonner Michael | Chief Financial Off ... | Buy | P | 6.72 | 300 | 2,016 | 15,997 | 15.7 K to 16 K (+1.91 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Bonner Michael | Chief Financial Off ... | Grant | A | 6.70 | 2,500 | 16,750 | 18,497 | 16 K to 18.5 K (+15.63 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Bonner Michael | Chief Financial Off ... | Buy | P | 6.72 | 300 | 2,016 | 15,997 | 15.7 K to 16 K (+1.91 %) |
| Dec 22 2017 | CPIX | CUMBERLAND PHARMAC ... | KAZIMI A J | Chairman and CEO | Gift | G | 0.00 | 15,000 | 0 | 5,830,270 | 5.8 M to 5.8 M (-0.26 %) |
| Nov 24 2017 | CPIX | CUMBERLAND PHARMAC ... | Krogulski Kenneth | Director | Buy | P | 7.55 | 3,300 | 24,915 | 154,300 | 151 K to 154.3 K (+2.19 %) |
| Nov 24 2017 | CPIX | CUMBERLAND PHARMAC ... | Bonner Michael | Chief Financial Off ... | Buy | P | 7.81 | 250 | 1,953 | 15,697 | 15.4 K to 15.7 K (+1.62 %) |
| Aug 25 2017 | CPIX | CUMBERLAND PHARMAC ... | Bonner Michael | Chief Financial Off ... | Buy | P | 6.72 | 500 | 3,360 | 15,447 | 14.9 K to 15.4 K (+3.35 %) |
| Jun 02 2017 | CPIX | CUMBERLAND PHARMAC ... | JACOBS JOEY A | Director | Grant | A | 6.53 | 4,000 | 26,120 | 61,000 | 57 K to 61 K (+7.02 %) |
| Jun 02 2017 | CPIX | CUMBERLAND PHARMAC ... | Griggs Jonathan | Director | Sell | S | 6.97 | 8,000 | 55,760 | 10,803 | 18.8 K to 10.8 K (-42.55 %) |
| Jun 02 2017 | CPIX | CUMBERLAND PHARMAC ... | Bonner Michael | Chief Financial Off ... | Buy | P | 6.95 | 300 | 2,085 | 14,947 | 14.6 K to 14.9 K (+2.05 %) |
| Apr 07 2017 | CPIX | CUMBERLAND PHARMAC ... | Young Caroline | Director | Grant | A | 6.45 | 2,000 | 12,900 | 2,000 | 0 to 2 K |
| Apr 07 2017 | CPIX | CUMBERLAND PHARMAC ... | JACOBS JOEY A | Director | Grant | A | 6.45 | 1,000 | 6,450 | 57,000 | 56 K to 57 K (+1.79 %) |
| Apr 07 2017 | CPIX | CUMBERLAND PHARMAC ... | Krogulski Kenneth | Director | Grant | A | 6.45 | 1,000 | 6,450 | 151,000 | 150 K to 151 K (+0.67 %) |
| Apr 07 2017 | CPIX | CUMBERLAND PHARMAC ... | Jones James | Director | Grant | A | 6.45 | 1,000 | 6,450 | 10,700 | 9.7 K to 10.7 K (+10.31 %) |
| Apr 07 2017 | CPIX | CUMBERLAND PHARMAC ... | Griggs Jonathan | Director | Grant | A | 6.45 | 1,000 | 6,450 | 18,803 | 17.8 K to 18.8 K (+5.62 %) |
| Apr 07 2017 | CPIX | CUMBERLAND PHARMAC ... | Bernard Gordon R | Director | Grant | A | 6.45 | 1,000 | 6,450 | 117,729 | 116.7 K to 117.7 K (+0.86 %) |
| Apr 07 2017 | CPIX | CUMBERLAND PHARMAC ... | Lawrence Thomas R | Director | Sell | S | 6.40 | 6,000 | 38,400 | 0 | 6 K to 0 (-100.00 %) |
| Apr 07 2017 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Payment of Exercise | F | 6.45 | 1,959 | 12,636 | 140,557 | 142.5 K to 140.6 K (-1.37 %) |
| Apr 07 2017 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Grant | A | 6.45 | 11,600 | 74,820 | 142,516 | 130.9 K to 142.5 K (+8.86 %) |
| Apr 07 2017 | CPIX | CUMBERLAND PHARMAC ... | Herman James L | VP and Chief Compli ... | Payment of Exercise | F | 6.45 | 1,796 | 11,584 | 42,948 | 44.7 K to 42.9 K (-4.01 %) |
| Apr 07 2017 | CPIX | CUMBERLAND PHARMAC ... | Herman James L | VP and Chief Compli ... | Grant | A | 6.45 | 6,000 | 38,700 | 44,744 | 38.7 K to 44.7 K (+15.49 %) |
| Apr 07 2017 | CPIX | CUMBERLAND PHARMAC ... | KAZIMI A J | Chairman and CEO | Payment of Exercise | F | 6.45 | 13,575 | 87,559 | 5,845,270 | 5.9 M to 5.8 M (-0.23 %) |
| Apr 07 2017 | CPIX | CUMBERLAND PHARMAC ... | KAZIMI A J | Chairman and CEO | Grant | A | 6.45 | 100,000 | 645,000 | 5,858,845 | 5.8 M to 5.9 M (+1.74 %) |
| Apr 07 2017 | CPIX | CUMBERLAND PHARMAC ... | Pavliv Leo | SVP and Chief Devel ... | Payment of Exercise | F | 6.45 | 3,582 | 23,104 | 107,861 | 111.4 K to 107.9 K (-3.21 %) |
| Apr 07 2017 | CPIX | CUMBERLAND PHARMAC ... | Pavliv Leo | SVP and Chief Devel ... | Grant | A | 6.45 | 10,000 | 64,500 | 111,443 | 101.4 K to 111.4 K (+9.86 %) |
| Apr 07 2017 | CPIX | CUMBERLAND PHARMAC ... | Bonner Michael | Chief Financial Off ... | Payment of Exercise | F | 6.45 | 653 | 4,212 | 14,647 | 15.3 K to 14.6 K (-4.27 %) |
| Apr 07 2017 | CPIX | CUMBERLAND PHARMAC ... | Bonner Michael | Chief Financial Off ... | Grant | A | 6.45 | 2,500 | 16,125 | 15,300 | 12.8 K to 15.3 K (+19.53 %) |
| Mar 24 2017 | CPIX | CUMBERLAND PHARMAC ... | Bonner Michael | Chief Financial Off ... | Buy | P | 6.42 | 900 | 5,778 | 12,800 | 11.9 K to 12.8 K (+7.56 %) |
| Mar 24 2017 | CPIX | CUMBERLAND PHARMAC ... | Krogulski Kenneth | Director | Buy | P | 6.53 | 15,000 | 97,950 | 150,000 | 135 K to 150 K (+11.11 %) |
| Mar 15 2017 | CPIX | CUMBERLAND PHARMAC ... | Lawrence Thomas R | Director | Sell | S | 6.24 | 20,781 | 129,673 | 6,000 | 26.8 K to 6 K (-77.60 %) |
| Nov 18 2016 | CPIX | CUMBERLAND PHARMAC ... | Lawrence Thomas R | Director | Sell | S | 5.07 | 18,600 | 94,302 | 26,781 | 45.4 K to 26.8 K (-40.99 %) |
| Nov 18 2016 | CPIX | CUMBERLAND PHARMAC ... | Bonner Michael | Chief Financial Off ... | Buy | P | 5.50 | 900 | 4,950 | 11,900 | 11 K to 11.9 K (+8.18 %) |
| Aug 19 2016 | CPIX | CUMBERLAND PHARMAC ... | Lawrence Thomas R | Director | Sell | S | 4.60 | 3,000 | 13,800 | 45,381 | 48.4 K to 45.4 K (-6.20 %) |
| May 27 2016 | CPIX | CUMBERLAND PHARMAC ... | Herman James L | VP and Chief Compli ... | Payment of Exercise | F | 4.51 | 3,840 | 17,318 | 38,744 | 42.6 K to 38.7 K (-9.02 %) |
| May 27 2016 | CPIX | CUMBERLAND PHARMAC ... | Pavliv Leo | SVP and Chief Devel ... | Payment of Exercise | F | 4.51 | 7,296 | 32,905 | 101,443 | 108.7 K to 101.4 K (-6.71 %) |
| May 27 2016 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Payment of Exercise | F | 4.51 | 3,960 | 17,860 | 130,916 | 134.9 K to 130.9 K (-2.94 %) |
| May 27 2016 | CPIX | CUMBERLAND PHARMAC ... | KAZIMI A J | Chairman and CEO | Payment of Exercise | F | 4.51 | 3,802 | 17,147 | 5,758,845 | 5.8 M to 5.8 M (-0.07 %) |
| May 27 2016 | CPIX | CUMBERLAND PHARMAC ... | Lawrence Thomas R | Director | Sell | S | 4.55 | 3,000 | 13,650 | 48,381 | 51.4 K to 48.4 K (-5.84 %) |
| Apr 08 2016 | CPIX | CUMBERLAND PHARMAC ... | Bonner Michael | Chief Financial Off ... | Grant | A | 4.34 | 5,000 | 21,700 | 11,000 | 6 K to 11 K (+83.33 %) |
| Apr 08 2016 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Payment of Exercise | F | 4.34 | 980 | 4,253 | 134,876 | 135.9 K to 134.9 K (-0.72 %) |
| Apr 08 2016 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Grant | A | 4.34 | 4,000 | 17,360 | 135,856 | 131.9 K to 135.9 K (+3.03 %) |
| Apr 08 2016 | CPIX | CUMBERLAND PHARMAC ... | KAZIMI A J | Chairman and CEO | Payment of Exercise | F | 4.34 | 9,857 | 42,779 | 5,762,647 | 5.8 M to 5.8 M (-0.17 %) |
| Apr 08 2016 | CPIX | CUMBERLAND PHARMAC ... | KAZIMI A J | Chairman and CEO | Grant | A | 4.34 | 100,000 | 434,000 | 5,772,504 | 5.7 M to 5.8 M (+1.76 %) |
| Apr 08 2016 | CPIX | CUMBERLAND PHARMAC ... | Herman James L | VP and Chief Compli ... | Payment of Exercise | F | 4.34 | 1,633 | 7,087 | 42,584 | 44.2 K to 42.6 K (-3.69 %) |
| Apr 08 2016 | CPIX | CUMBERLAND PHARMAC ... | Herman James L | VP and Chief Compli ... | Grant | A | 4.34 | 2,750 | 11,935 | 44,217 | 41.5 K to 44.2 K (+6.63 %) |
| Apr 08 2016 | CPIX | CUMBERLAND PHARMAC ... | Pavliv Leo | SVP and Chief Devel ... | Payment of Exercise | F | 4.34 | 3,851 | 16,713 | 108,739 | 112.6 K to 108.7 K (-3.42 %) |
| Apr 08 2016 | CPIX | CUMBERLAND PHARMAC ... | Pavliv Leo | SVP and Chief Devel ... | Grant | A | 4.34 | 5,000 | 21,700 | 112,590 | 107.6 K to 112.6 K (+4.65 %) |
| Apr 08 2016 | CPIX | CUMBERLAND PHARMAC ... | Bernard Gordon R | Director | Grant | A | 4.34 | 1,000 | 4,340 | 116,729 | 115.7 K to 116.7 K (+0.86 %) |
| Apr 08 2016 | CPIX | CUMBERLAND PHARMAC ... | Jones James | Director | Grant | A | 4.34 | 1,000 | 4,340 | 9,700 | 8.7 K to 9.7 K (+11.49 %) |
| Apr 08 2016 | CPIX | CUMBERLAND PHARMAC ... | JACOBS JOEY A | Director | Grant | A | 4.34 | 1,000 | 4,340 | 56,000 | 55 K to 56 K (+1.82 %) |
| Apr 08 2016 | CPIX | CUMBERLAND PHARMAC ... | Griggs Jonathan | Director | Grant | A | 4.34 | 1,000 | 4,340 | 17,803 | 16.8 K to 17.8 K (+5.95 %) |
| Apr 08 2016 | CPIX | CUMBERLAND PHARMAC ... | Lawrence Thomas R | Director | Grant | A | 4.34 | 6,000 | 26,040 | 51,381 | 45.4 K to 51.4 K (+13.22 %) |
| Apr 08 2016 | CPIX | CUMBERLAND PHARMAC ... | Lawrence Thomas R | Director | Sell | S | 4.34 | 5,000 | 21,700 | 45,381 | 50.4 K to 45.4 K (-9.92 %) |
| Dec 31 2015 | CPIX | CUMBERLAND PHARMAC ... | KAZIMI A J | Chairman and CEO | Gift | G | 0.00 | 60,000 | 0 | 5,672,504 | 5.7 M to 5.7 M (-1.05 %) |
| Dec 04 2015 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Grant | A | 5.58 | 1,950 | 10,881 | 131,856 | 129.9 K to 131.9 K (+1.50 %) |
| Dec 04 2015 | CPIX | CUMBERLAND PHARMAC ... | Pavliv Leo | SVP and Chief Devel ... | Grant | A | 5.58 | 6,500 | 36,270 | 107,590 | 101.1 K to 107.6 K (+6.43 %) |
| Dec 04 2015 | CPIX | CUMBERLAND PHARMAC ... | Herman James L | VP and Chief Compli ... | Grant | A | 5.58 | 5,775 | 32,225 | 41,467 | 35.7 K to 41.5 K (+16.18 %) |
| Nov 20 2015 | CPIX | CUMBERLAND PHARMAC ... | Lawrence Thomas R | Director | Sell | S | 5.61 | 4,000 | 22,440 | 50,381 | 54.4 K to 50.4 K (-7.36 %) |
| May 28 2015 | CPIX | CUMBERLAND PHARMAC ... | Lawrence Thomas R | Director | Sell | S | 6.88 | 6,000 | 41,280 | 54,381 | 60.4 K to 54.4 K (-9.94 %) |
| May 01 2015 | CPIX | CUMBERLAND PHARMAC ... | Griggs Jonathan | Director | Option Exercise | M | 6.69 | 700 | 4,683 | 0 | |
| May 01 2015 | CPIX | CUMBERLAND PHARMAC ... | Griggs Jonathan | Director | Buy | M | 6.69 | 700 | 4,683 | 6,645 | 5.9 K to 6.6 K (+11.77 %) |
| Mar 27 2015 | CPIX | CUMBERLAND PHARMAC ... | Pavliv Leo | SVP and Chief Devel ... | Payment of Exercise | F | 6.88 | 1,605 | 11,042 | 101,090 | 102.7 K to 101.1 K (-1.56 %) |
| Mar 27 2015 | CPIX | CUMBERLAND PHARMAC ... | Pavliv Leo | SVP and Chief Devel ... | Grant | A | 6.86 | 5,000 | 34,300 | 102,695 | 97.7 K to 102.7 K (+5.12 %) |
| Mar 27 2015 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Payment of Exercise | F | 6.88 | 794 | 5,463 | 129,906 | 130.7 K to 129.9 K (-0.61 %) |
| Mar 27 2015 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Grant | A | 6.86 | 3,000 | 20,580 | 130,700 | 127.7 K to 130.7 K (+2.35 %) |
| Mar 27 2015 | CPIX | CUMBERLAND PHARMAC ... | Herman James L | VP and Chief Compli ... | Payment of Exercise | F | 6.88 | 817 | 5,621 | 35,692 | 36.5 K to 35.7 K (-2.24 %) |
| Mar 27 2015 | CPIX | CUMBERLAND PHARMAC ... | Herman James L | VP and Chief Compli ... | Grant | A | 6.86 | 4,000 | 27,440 | 36,509 | 32.5 K to 36.5 K (+12.30 %) |
| Mar 27 2015 | CPIX | CUMBERLAND PHARMAC ... | KAZIMI A J | Chairman and CEO | Payment of Exercise | F | 6.88 | 6,838 | 47,045 | 5,732,504 | 5.7 M to 5.7 M (-0.12 %) |
| Mar 27 2015 | CPIX | CUMBERLAND PHARMAC ... | KAZIMI A J | Chairman and CEO | Grant | A | 6.86 | 100,000 | 686,000 | 5,739,342 | 5.6 M to 5.7 M (+1.77 %) |
| Mar 27 2015 | CPIX | CUMBERLAND PHARMAC ... | Greene Rick Scott | Chief Financial Off ... | Grant | A | 6.86 | 3,000 | 20,580 | 45,000 | 42 K to 45 K (+7.14 %) |
| Mar 27 2015 | CPIX | CUMBERLAND PHARMAC ... | Jones James | Director | Grant | A | 6.86 | 1,000 | 6,860 | 8,000 | 7 K to 8 K (+14.29 %) |
| Mar 27 2015 | CPIX | CUMBERLAND PHARMAC ... | JACOBS JOEY A | Director | Grant | A | 6.86 | 1,000 | 6,860 | 55,000 | 54 K to 55 K (+1.85 %) |
| Mar 27 2015 | CPIX | CUMBERLAND PHARMAC ... | Lawrence Thomas R | Director | Grant | A | 6.86 | 11,000 | 75,460 | 60,381 | 49.4 K to 60.4 K (+22.28 %) |
| Mar 27 2015 | CPIX | CUMBERLAND PHARMAC ... | Bernard Gordon R | Director | Grant | A | 6.86 | 1,000 | 6,860 | 115,729 | 114.7 K to 115.7 K (+0.87 %) |
| Mar 27 2015 | CPIX | CUMBERLAND PHARMAC ... | Griggs Jonathan | Director | Grant | A | 6.86 | 1,000 | 6,860 | 5,945 | 4.9 K to 5.9 K (+20.22 %) |
| Mar 20 2015 | CPIX | CUMBERLAND PHARMAC ... | Lawrence Thomas R | Director | Sell | S | 6.95 | 6,000 | 41,700 | 49,381 | 55.4 K to 49.4 K (-10.83 %) |
| Nov 21 2014 | CPIX | CUMBERLAND PHARMAC ... | Lawrence Thomas R | Director | Sell | S | 5.12 | 10,000 | 51,200 | 55,381 | 65.4 K to 55.4 K (-15.29 %) |
| Aug 22 2014 | CPIX | CUMBERLAND PHARMAC ... | Lawrence Thomas R | Director | Sell | S | 5.08 | 15,000 | 76,200 | 65,381 | 80.4 K to 65.4 K (-18.66 %) |
| Mar 21 2014 | CPIX | CUMBERLAND PHARMAC ... | Pavliv Leo | SVP and Chief Devel ... | Grant | A | 4.58 | 5,000 | 22,900 | 97,695 | 92.7 K to 97.7 K (+5.39 %) |
| Mar 21 2014 | CPIX | CUMBERLAND PHARMAC ... | Lawrence Thomas R | Director | Sell | S | 4.54 | 20,000 | 90,800 | 80,381 | 100.4 K to 80.4 K (-19.92 %) |
| Mar 21 2014 | CPIX | CUMBERLAND PHARMAC ... | Lawrence Thomas R | Director | Grant | A | 4.58 | 1,000 | 4,580 | 100,381 | 99.4 K to 100.4 K (+1.01 %) |
| Mar 21 2014 | CPIX | CUMBERLAND PHARMAC ... | KAZIMI A J | Chairman and CEO | Grant | A | 4.58 | 75,000 | 343,500 | 5,639,342 | 5.6 M to 5.6 M (+1.35 %) |
| Mar 21 2014 | CPIX | CUMBERLAND PHARMAC ... | Jones James | Director | Grant | A | 4.58 | 1,000 | 4,580 | 7,000 | 6 K to 7 K (+16.67 %) |
| Mar 21 2014 | CPIX | CUMBERLAND PHARMAC ... | JACOBS JOEY A | Director | Grant | A | 4.58 | 1,000 | 4,580 | 54,000 | 53 K to 54 K (+1.89 %) |
| Mar 21 2014 | CPIX | CUMBERLAND PHARMAC ... | Herman James L | VP and Chief Compli ... | Grant | A | 4.58 | 7,750 | 35,495 | 32,509 | 24.8 K to 32.5 K (+31.30 %) |
| Mar 21 2014 | CPIX | CUMBERLAND PHARMAC ... | Griggs Jonathan | Director | Grant | A | 4.58 | 1,000 | 4,580 | 4,945 | 3.9 K to 4.9 K (+25.35 %) |
| Mar 21 2014 | CPIX | CUMBERLAND PHARMAC ... | Greene Rick Scott | Chief Financial Off ... | Grant | A | 4.58 | 3,000 | 13,740 | 42,000 | 39 K to 42 K (+7.69 %) |
| Mar 21 2014 | CPIX | CUMBERLAND PHARMAC ... | Edwards Robert | Director | Grant | A | 4.58 | 1,000 | 4,580 | 417,569 | 416.6 K to 417.6 K (+0.24 %) |
| Mar 21 2014 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Grant | A | 4.58 | 3,000 | 13,740 | 127,700 | 124.7 K to 127.7 K (+2.41 %) |
| Mar 21 2014 | CPIX | CUMBERLAND PHARMAC ... | Bernard Gordon R | Director | Grant | A | 4.58 | 1,000 | 4,580 | 114,729 | 113.7 K to 114.7 K (+0.88 %) |
| Nov 25 2013 | CPIX | CUMBERLAND PHARMAC ... | Lawrence Thomas R | Director | Sell | S | 4.99 | 12,000 | 59,880 | 99,381 | 111.4 K to 99.4 K (-10.77 %) |
| Mar 27 2013 | CPIX | CUMBERLAND PHARMAC ... | Herman James L | VP and Corporate Co ... | Grant | A | 4.78 | 5,500 | 26,290 | 24,759 | 19.3 K to 24.8 K (+28.56 %) |
| Mar 27 2013 | CPIX | CUMBERLAND PHARMAC ... | Pavliv Leo | SVP and Chief Devel ... | Grant | A | 4.78 | 10,000 | 47,800 | 92,695 | 102.7 K to 92.7 K (-9.74 %) |
| Mar 27 2013 | CPIX | CUMBERLAND PHARMAC ... | Jones James | Director | Grant | A | 4.78 | 1,000 | 4,780 | 6,000 | 5 K to 6 K (+20.00 %) |
| Mar 27 2013 | CPIX | CUMBERLAND PHARMAC ... | Lawrence Thomas R | Director | Grant | A | 4.78 | 1,000 | 4,780 | 192,354 | 191.4 K to 192.4 K (+0.52 %) |
| Mar 27 2013 | CPIX | CUMBERLAND PHARMAC ... | KAZIMI A J | Chairman and CEO | Grant | A | 4.78 | 50,000 | 239,000 | 5,564,342 | 5.5 M to 5.6 M (+0.91 %) |
| Mar 27 2013 | CPIX | CUMBERLAND PHARMAC ... | JACOBS JOEY A | Director | Grant | A | 4.78 | 1,000 | 4,780 | 53,000 | 52 K to 53 K (+1.92 %) |
| Mar 27 2013 | CPIX | CUMBERLAND PHARMAC ... | Griggs Jonathan | Director | Grant | A | 4.78 | 1,000 | 4,780 | 3,945 | 2.9 K to 3.9 K (+33.96 %) |
| Mar 27 2013 | CPIX | CUMBERLAND PHARMAC ... | Greene Rick Scott | Chief Financial Off ... | Grant | A | 4.78 | 6,000 | 28,680 | 39,000 | 33 K to 39 K (+18.18 %) |
| Mar 27 2013 | CPIX | CUMBERLAND PHARMAC ... | Edwards Robert | Director | Grant | A | 4.78 | 1,000 | 4,780 | 416,569 | 415.6 K to 416.6 K (+0.24 %) |
| Mar 27 2013 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Grant | A | 4.78 | 6,000 | 28,680 | 124,700 | 118.7 K to 124.7 K (+5.05 %) |
| Mar 27 2013 | CPIX | CUMBERLAND PHARMAC ... | Bernard Gordon R | Director | Grant | A | 4.78 | 1,000 | 4,780 | 113,729 | 112.7 K to 113.7 K (+0.89 %) |
| Mar 27 2013 | CPIX | CUMBERLAND PHARMAC ... | Bernard Gordon R | Director | Grant | A | 4.78 | 1,000 | 4,780 | 113,729 | 112.7 K to 113.7 K (+0.89 %) |
| Mar 20 2013 | CPIX | CUMBERLAND PHARMAC ... | Pavliv Leo | SVP and Chief Devel ... | Option Exercise | M | 3.50 | 160,000 | 560,000 | 0 | |
| Mar 20 2013 | CPIX | CUMBERLAND PHARMAC ... | Pavliv Leo | SVP and Chief Devel ... | Payment of Exercise | F | 4.78 | 132,700 | 634,306 | 92,695 | 225.4 K to 92.7 K (-58.87 %) |
| Mar 20 2013 | CPIX | CUMBERLAND PHARMAC ... | Pavliv Leo | SVP and Chief Devel ... | Buy | M | 3.50 | 160,000 | 560,000 | 225,395 | 65.4 K to 225.4 K (+244.67 %) |
| Nov 16 2012 | CPIX | CUMBERLAND PHARMAC ... | Marstiller Jean W | Sr. VP & Corp. Secr ... | Option Exercise | M | 3.50 | 400 | 1,400 | 0 | |
| Nov 16 2012 | CPIX | CUMBERLAND PHARMAC ... | Marstiller Jean W | Sr. VP & Corp. Secr ... | Buy | M | 3.50 | 400 | 1,400 | 440,828 | 440.4 K to 440.8 K (+0.09 %) |
| Nov 16 2012 | CPIX | CUMBERLAND PHARMAC ... | Lawrence Thomas R | Director | Option Exercise | M | 3.50 | 8,000 | 28,000 | 0 | |
| Nov 16 2012 | CPIX | CUMBERLAND PHARMAC ... | Lawrence Thomas R | Director | Sell | S | 4.45 | 6,222 | 27,688 | 191,354 | 197.6 K to 191.4 K (-3.15 %) |
| Nov 16 2012 | CPIX | CUMBERLAND PHARMAC ... | Lawrence Thomas R | Director | Buy | M | 3.50 | 8,000 | 28,000 | 197,576 | 189.6 K to 197.6 K (+4.22 %) |
| May 24 2012 | CPIX | CUMBERLAND PHARMAC ... | Pavliv Leo | SVP and Chief Devel ... | Option Exercise | A | 0.00 | 18,950 | 0 | 18,950 | |
| May 24 2012 | CPIX | CUMBERLAND PHARMAC ... | Pavliv Leo | SVP and Chief Devel ... | Option Exercise | D | 11.29 | 12,000 | 135,480 | 0 | |
| May 24 2012 | CPIX | CUMBERLAND PHARMAC ... | Pavliv Leo | SVP and Chief Devel ... | Option Exercise | D | 11.00 | 12,000 | 132,000 | 0 | |
| May 24 2012 | CPIX | CUMBERLAND PHARMAC ... | Pavliv Leo | SVP and Chief Devel ... | Option Exercise | D | 13.00 | 9,000 | 117,000 | 0 | |
| May 24 2012 | CPIX | CUMBERLAND PHARMAC ... | Pavliv Leo | SVP and Chief Devel ... | Option Exercise | D | 13.00 | 10,000 | 130,000 | 0 | |
| May 24 2012 | CPIX | CUMBERLAND PHARMAC ... | Marstiller Jean W | Sr. VP & Corp. Secr ... | Option Exercise | A | 0.00 | 20,946 | 0 | 20,946 | |
| May 24 2012 | CPIX | CUMBERLAND PHARMAC ... | Marstiller Jean W | Sr. VP & Corp. Secr ... | Option Exercise | D | 11.29 | 8,000 | 90,320 | 0 | |
| May 24 2012 | CPIX | CUMBERLAND PHARMAC ... | Marstiller Jean W | Sr. VP & Corp. Secr ... | Option Exercise | D | 9.00 | 11,000 | 99,000 | 0 | |
| May 24 2012 | CPIX | CUMBERLAND PHARMAC ... | Marstiller Jean W | Sr. VP & Corp. Secr ... | Option Exercise | D | 11.00 | 12,000 | 132,000 | 0 | |
| May 24 2012 | CPIX | CUMBERLAND PHARMAC ... | Marstiller Jean W | Sr. VP & Corp. Secr ... | Option Exercise | D | 13.00 | 9,000 | 117,000 | 0 | |
| May 24 2012 | CPIX | CUMBERLAND PHARMAC ... | Marstiller Jean W | Sr. VP & Corp. Secr ... | Option Exercise | D | 13.00 | 9,000 | 117,000 | 0 | |
| May 24 2012 | CPIX | CUMBERLAND PHARMAC ... | KAZIMI A J | Chairman and CEO | Option Exercise | A | 0.00 | 13,497 | 0 | 13,497 | |
| May 24 2012 | CPIX | CUMBERLAND PHARMAC ... | KAZIMI A J | Chairman and CEO | Option Exercise | D | 12.42 | 50,000 | 621,000 | 0 |